Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Saraswanti Anugerah Makmur Tbk. (SAMF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Saraswanti Anugerah Makmur Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume), while Saraswanti Anugerah Makmur Tbk. trades at Rp284 (market cap 2.89T, 66.7K 24h volume). The key difference: Saraswanti Anugerah Makmur Tbk. is far larger — about 17.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (187.4K versus 66.7K). Which is the better fit depends on your goals.
| OBAT | SAMF | |
|---|---|---|
Market Cap | 164.65B | 2.89T |
Volume | 187.4K | 66.7K |
Lot | 1.87K | 667 |
Turnover | 44.35M | 18.79M |
Average Price | 236.67 | 281.67 |
Value | 44.35M | 18.79M |
Indicative Equilibrium Price | 242 | — |
Indicative Equilibrium Volume | 500 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Saraswanti Anugerah Makmur Tbk.
PT. Saraswanti Anugerah Makmur Tbk. (the Company) was established based on the Notarial Deed of Titiek Lintang Trenggonowati, S.H., No.15 dated June 18, 1998, notary in Surabaya.
Read more on SAMF →
